IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD Meeting Abstract
| Authors: | Lindemans, C. A.; Mertelsmann, A.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; Luo, N.; Ivanov, J.; Hua, G.; Martin, M. L.; Liu, C.; Kolesnick, R.; Van Den Brink, M.; Hanash, A. M. |
| Abstract Title: | IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349242700094 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.651.651 |
| Notes: | Meeting Abstract: 651 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work